FINOTTI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.839
AS - Asia 2.108
EU - Europa 1.071
SA - Sud America 342
AF - Africa 268
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 24
Totale 7.679
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.638
SG - Singapore 751
CN - Cina 408
DE - Germania 282
VN - Vietnam 226
BR - Brasile 210
HK - Hong Kong 198
FI - Finlandia 111
IT - Italia 98
BD - Bangladesh 88
FR - Francia 82
UA - Ucraina 73
IN - India 62
SE - Svezia 59
GB - Regno Unito 57
PL - Polonia 35
AR - Argentina 33
CA - Canada 32
PK - Pakistan 32
NL - Olanda 27
RU - Federazione Russa 26
TR - Turchia 26
PH - Filippine 23
EC - Ecuador 22
JP - Giappone 20
MX - Messico 20
SA - Arabia Saudita 19
PS - Palestinian Territory 18
BE - Belgio 16
JM - Giamaica 16
MY - Malesia 16
UZ - Uzbekistan 16
IQ - Iraq 15
ZA - Sudafrica 15
CO - Colombia 14
ID - Indonesia 14
JO - Giordania 14
PR - Porto Rico 14
VE - Venezuela 14
GM - Gambi 12
HU - Ungheria 12
MA - Marocco 12
PT - Portogallo 12
TN - Tunisia 12
UY - Uruguay 12
BB - Barbados 11
ES - Italia 11
KE - Kenya 11
AE - Emirati Arabi Uniti 10
AT - Austria 10
CL - Cile 10
IE - Irlanda 10
KG - Kirghizistan 10
KZ - Kazakistan 10
LA - Repubblica Popolare Democratica del Laos 10
NC - Nuova Caledonia 10
RS - Serbia 10
SI - Slovenia 10
SN - Senegal 10
YE - Yemen 10
AL - Albania 9
AZ - Azerbaigian 9
IR - Iran 9
MK - Macedonia 9
TH - Thailandia 9
XK - ???statistics.table.value.countryCode.XK??? 9
AF - Afghanistan, Repubblica islamica di 8
AM - Armenia 8
BZ - Belize 8
CH - Svizzera 8
CR - Costa Rica 8
CU - Cuba 8
CV - Capo Verde 8
DO - Repubblica Dominicana 8
EE - Estonia 8
GE - Georgia 8
GF - Guiana Francese 8
GR - Grecia 8
HR - Croazia 8
KH - Cambogia 8
LT - Lituania 8
MW - Malawi 8
NI - Nicaragua 8
PY - Paraguay 8
RW - Ruanda 8
TT - Trinidad e Tobago 8
UG - Uganda 8
AO - Angola 7
BG - Bulgaria 7
CI - Costa d'Avorio 7
CW - ???statistics.table.value.countryCode.CW??? 7
EG - Egitto 7
GH - Ghana 7
GT - Guatemala 7
LB - Libano 7
MZ - Mozambico 7
RO - Romania 7
VC - Saint Vincent e Grenadine 7
YT - Mayotte 7
AD - Andorra 6
Totale 7.377
Salva come PNG Salva come JPEG
Città #
Singapore 482
Ashburn 435
San Jose 409
Fairfield 274
Jacksonville 238
Chandler 224
Woodbridge 217
Ann Arbor 198
Houston 194
Hong Kong 182
Wilmington 132
Cambridge 115
Seattle 100
Beijing 95
Princeton 77
Santa Clara 73
Boardman 66
Helsinki 63
Los Angeles 61
Hanoi 57
Ho Chi Minh City 57
Lauterbourg 43
Nanjing 40
Roxbury 32
San Diego 32
Des Moines 31
Medford 29
New York 26
Nürnberg 25
São Paulo 23
Dong Ket 22
Padova 22
Shenyang 20
Guangzhou 19
Bytom 17
Chicago 16
Tashkent 15
Amman 13
Hebei 13
Orem 13
Tokyo 13
Warsaw 13
Boston 12
Buffalo 12
Kingston 12
Rome 12
Atlanta 11
Toronto 11
Bridgetown 10
Dakar 10
Kuala Lumpur 10
Lahore 10
Noumea 10
Stockholm 10
Bishkek 9
Da Nang 9
Montevideo 9
Nairobi 9
Norwalk 9
Redwood City 9
San Juan 9
Vientiane 9
Baku 8
Council Bluffs 8
Dublin 8
Frankfurt am Main 8
Kampala 8
Kigali 8
Managua 8
Milan 8
New Delhi 8
Phnom Penh 8
Vienna 8
Yerevan 8
Abu Dhabi 7
Accra 7
Athens 7
Bangkok 7
Belize City 7
Brooklyn 7
Guayaquil 7
Haiphong 7
Havana 7
Jinan 7
Kingstown 7
Lilongwe 7
Montreal 7
Riyadh 7
San Francisco 7
San José 7
Skopje 7
Abidjan 6
Andorra la Vella 6
Bamako 6
Banjul 6
Brussels 6
Conakry 6
Dallas 6
Dushanbe 6
Hyderabad 6
Totale 4.697
Salva come PNG Salva come JPEG
Nome #
Identification and purification from the plasma of Type 1 diabetic subjects of a proteolytically active Grp94Evidence that Grp94 is entirely responsible for plasma proteolytic activity. 321
Grp94 in complexes with IgG is a soluble diagnostic marker of gastrointestinal tumors and displays immune-stimulating activity on peripheral blood immune cells 312
Angiogenic transforming capacity of IgG purified from plasma of type 1 diabetic patients 262
Crucial role of HSP90 in the Akt-dependent promotion of angiogenic-like effect of Glucose-regulated protein94 (Grp94)-IgG complexes 259
Proteomic investigation on Grp94-IgG complexes circulating in plasma of type 1 diabetic subjects 254
Human IgGs induce synthesis and secretion of IgGs and neonatal Fc receptor in human umbilical vein endothelial cells 254
Characterization of immune complexes of idiotypic catalytic and anti-idiotypic inhibitory antibodies in plasma of type 1 diabetic subjects 245
Stable complexes formed by Grp94 with human IgG promoting angiogenic differentiation of HUVECs by a cytokine-like mechanism. 244
Structural Insights into Complexes of Glucose-Regulated Protein94 (Grp94) with Human Immunoglobulin G. Relevance for Grp94-IgG Complexes that Form In Vivo in Pathological Conditions 237
Alteration of plasma proteinase-antiproteinase system in type 1 diabetic patients. Influence of sex and relationship with metabolic control. 214
Long-term blood glucose control and diabetic retinopathy. 203
Comment on: Antibodies to the endoplasmic reticulum-resident chaperones calnexin, Bip and Grp94 in patients with rheumatoid arthritis and systemic lupus erythematosus 202
Effects of Glucose-regulated protein94 (Grp94) on Ig secretion from human blood mononuclear cells 191
The role played by serine proteases in the development and worsening of vascular complications in Type 1 diabetes mellitus. 188
Albumin contamination of a purified human alpha1-antitrypsin preparation does not affect either structural conformation or the electrophoretic mobility of the inhibitor. 168
Inhibition of immunoglobulin secretion from peripheral blood mononuclear cells by glucose-regulated protein94 (Grp94) inallergic subjects 167
Mechanism of Na+/K(+)-ATPase activation by trypsin and kallikrein. 166
A heat shock protein70 fusion protein with alpha(1)-antitrypsin in plasma of Type 1 diabetic subjects 162
[Effects of digoxin on plasma renin activity in man. II]. 159
Immune complexes of Glucose-regulated protein94 (Grp94) with IgG are present in the plasma of Type 1 diabetic subjects and show strong angiogenic-transforming capacity on HUVECs (oral communication) 158
Differential Mechanism for structural and functional alterations of trypsin by heparin, evidence for a speific radical-generating mechanism at low heparin concentrations. 158
Complexes of Grp94 with human Immunoglobulin G 157
Immune complexes of glucose-regulated protein94 (Grp94) with IgG, present in the plasma of type 1 diabetic subjects, show strong angiogenic-transforming capacity on HUVECs 154
Separation by heparin-affinity chromatography of catalytically active and inactive forms of trypsin which retain the (Na-K)ATPase stimulating property. 154
Complessi di Grp94 ed Immunoglobuline G umane 152
Effects of Glucose-Regulated Protein94 (GRP94) and complexes of GRP94 with IgG on cells of the innate and adaptive immunity (SIF award for the best oral communication) 152
Biphasic pattern of heparin-induced oxidative degradation of trypsin in the presence of glucose. 151
Reduction of erythrocyte (Na+-K+)ATPase activity in type 1 (insulin-dependent) diabetic subjects and its activation by homologous plasma. 149
Heparin-induced structural modifications and oxidative cleavage of human serum albumin in the absence and presence of glucose. 138
Role of reducing terminals in unfractionated and low-molecular-mass heparins in causing free radical generation and loss of structure and activity of tripsin. 136
The oxidative mechanism of heparin interferes with radical production by glucose and reduces the degree of glycooxidative modifications on human serum albumin 133
Differential effects of heparin and glucose on structural conformation of human alpha1-antitrypsin: evidence for a heparin-induced cleaved form of the inhibitor. 131
Kinetic studies with competitive inhibitors indicate a sequential mechanism for dopamine beta-hydroxylase. 128
Effects of digoxin on plasma renin activity in hypertensive patients. 123
Effects of intact and reduced reducing termini in heparin on structural and functional modifications of trypsin. 122
Induction of angiogenesis by the heat shock protein Glucose-regulated protein94 (Grp94) mediated by a cytokine-like mechanism. 119
Heparin-induced structural and functional alterations of bovine trypsin. 111
Inhibition of dopamine beta-hydroxylase by captopril. 110
New insights into the molecular mechanism of heparin-protein interactions. Revisiting the role and function of heparin in the light of its oxidative property 108
Both a serine-like protease and a protease inhibitory activity are present in circulating immune complexes in type 1 diabetes mellitus. 106
Spin-trapping agent alpha-phenyl N-tert-butylnitrone binds to trypsin and enhances heparin-induced inhibition of amidolytic activity and structural degradation of the enzyme. 99
Sex and parental hypertension as predictors of worsened red blood cell membrane enzyme activities in type 1 insulin-dependent diabetic subjects. 97
IDENTIFICAZIONE DI UNA " GLUCOSE-REGULATED PROTEIN" 94 GRP94 MODIFICATA E USO DELLA STESSA E DI ANTICORPI ANTI-GRP94 NELLE COMPLICANZE VASCOLARI DEL DIABETE 91
Heparin effects on glycated human serum albumin 90
Spin-trapping agent alpha-phenyl N-Tert-butylnitrone as inhibitor of trypsin and enhancer of the oxidative degradation of the enzyme by heparin 86
Purification of proteinase-like and Na+/K(+)-ATPase stimulating substance from plasma of insulin-dependent diabetics and its identification as alpha 1-antitrypsin 82
Inhibition of enzymes and enzyme by phenothiazines and their radicals. In: Phenothiazienes and 1,4-benzothiazines 76
Totale 7.679
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.264
article - articoli 18.051
book - libri 285
conference - conferenze 0
curatela - curatele 0
other - altro 253
patent - brevetti 818
selected - selezionate 0
volume - volumi 0
Totale 41.671
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022470 0 64 44 42 21 38 16 47 26 9 45 118
2022/2023454 90 63 12 42 68 76 0 31 41 1 25 5
2023/2024224 17 34 29 19 31 15 18 5 2 3 26 25
2024/2025851 0 37 35 51 138 25 36 63 84 20 150 212
2025/20263.582 128 278 387 528 361 159 491 343 381 232 154 140
2026/2027134 119 15 0 0 0 0 0 0 0 0 0 0
Totale 7.679